Evidence map›Paper›PMID 31548678›Full record

ArticleNature human behaviour2019

Brain regulation of emotional conflict predicts antidepressant treatment response for depression.

Gregory A Fonzo, Amit Etkin, Yu Zhang, Wei Wu, Crystal Cooper, Cherise Chin-Fatt, Manish K Jha, Joseph Trombello, Thilo Deckersbach, Phil Adams and 5 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature human behaviour, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07222306 (Investigating the Therapeutic Impact of Cannabinoids on Neuroinflammation and Neurobiological Underpinnings of Suicide Ideation in Veterans With PTSD), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07222306 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Investigating the Therapeutic Impact of Cannabinoids on Neuroinflammation and Neurobiological Underpinnings of Suicide Ideation in Veterans With PTSD

TypeobservationalSponsorWayne State UniversityRan2026 to 2030Enrolled100ConditionsPTSD, Suicidal Thoughts and Behaviors, PTSD Symptoms, Depressive SymptomsArms1-(2-[+F]fluoroethyl)-L-tryptophan
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Gregory A Fonzo *Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Amit Etkin *Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. amitetkin@stanford.edu.ORCID http://orcid.org/0000-0001-8259-3521
Yu Zhang *Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4087-6544
Wei WuDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1901-9134
Crystal CooperDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cherise Chin-FattDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Manish K JhaDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Joseph TrombelloDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-4953-3831
Thilo DeckersbachDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Phil AdamsNew York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Melvin McInnisDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Patrick J McGrathNew York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Myrna M WeissmanNew York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0003-3490-3075
Maurizio FavaDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4635-0458
Madhukar H TrivediDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2983-1110
The University of Texas Southwestern Medical Center · USColumbia University · USNeurosciences Institute · USMassachusetts General Hospital · USThe University of Texas at Austin · USUniversity of Michigan · US

Funding

Establishing Moderators/Biosignatures of Antidepressant Response- Clinical CareU01MH092221 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2010 to 2015
$9.7M
Biosignatures of Treatment Remission in Major DepressionU01MH092250 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MCGRATH, PATRICK J, PARSEY, RAMIN V. · 2010 to 2015
$8.9M
NIMH NIH HHS U01 MH092221NIMH NIH HHS U01 MH092250
6 · The paper itself

Abstract

The efficacy of antidepressant treatment for depression is controversial due to the only modest superiority demonstrated over placebo. However, neurobiological heterogeneity within depression may limit overall antidepressant efficacy. We sought to identify a neurobiological phenotype responsive to antidepressant treatment by testing pretreatment brain activation during response to, and regulation of, emotional conflict as a moderator of the clinical benefit of the antidepressant sertraline versus placebo. Using neuroimaging data from a large randomized controlled trial, we found widespread moderation of clinical benefits by brain activity during regulation of emotional conflict, in which greater downregulation of conflict-responsive regions predicted better sertraline outcomes. Treatment-predictive machine learning using brain metrics outperformed a model trained on clinical and demographic variables. Our findings demonstrate that antidepressant response is predicted by brain activity underlying a key self-regulatory emotional capacity. Leveraging brain-based measures in psychiatry will forge a path toward better treatment personalization, refined mechanistic insights and improved outcomes.

Indexed as

Antidepressive AgentsAntidepressive Agents, Second-GenerationBrainClinical Trials as TopicDepressionHumansMagnetic Resonance ImagingMajor Depressive DisorderNeuroimagingTreatment OutcomeAntidepressive AgentsAntidepressive Agents, Second-Generation

Identifiers

PMID31548678
PMCPMC6908746
OpenAlexW2974871203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.